Resources
-
Singapore’s New Cell, Tissue and Gene Therapy Products Regulations
Speaker Presentation Kellathur Srinivasan, Health Sciences Authority, 2021
-
Regulation of Cell and Gene Therapies in Australia
Speaker Presentation Hislop Andrew, Therapuetic Goods Administration, 2021
-
Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (BGTC)
Speaker Presentation Hoffman Steve, The Foundation for the National Institutes of Health, 2021
-
Overcoming the Challenges Getting ATMPs Approved in the European Union
Speaker Presentation Celis Patrick, European Medicines Agency (EMA), 2021
-
Emergence and Advancement of Technologies: Regulatory Challenges and Considerations
Speaker Presentation Haile Yohannes, Health Canada, 2021
-
ATMPs in the UK: Routes to Market and Avoiding “Trees on the Track”
Speaker Presentation Bisset Louise, MHRA- Medicines and Healthcare Products Regulatory Agency, 2021
-
Trending MS Topic via Attendee Polling - Analytical Mass Spectrometry Challenges with New Modalities
Roundtable 12 Notes: Mass Spec 2021
-
mRNA Characterization by MS – What Are the PQAs and What Are the Methods
Roundtable 11 Notes: Mass Spec 2021
-
Successful Implementation of Top/middle Down MSMS for Characterization
Roundtable 10 Notes: Mass Spec 2021
-
Best Practices for Reporting MS Data in Regulatory Filings
Roundtable 9 Notes: Mass Spec 2021
-
MS of RNA and Oligonucleotides - Minimizing Adducts and Quantitation Best Practices
Roundtable 8 Notes: Mass Spec 2021
-
MS Data Analysis - Feedback and Suggestions to Improve Software Tools
Roundtable 7 Notes: Mass Spec 2021
-
Structural MS - New Developments in Limited Digestion, HDX, FPOP and Ion Mobility
Roundtable 6 Notes: Mass Spec 2021
-
Best Practices for Predicting, Elucidating and Monitoring Hotspots by MS
Roundtable 5 Notes: Mass Spec 2021
-
Tips and Tricks for Automated MS Data Analysis
Roundtable 4 Notes: Mass Spec 2021
-
Deep Dive into HCPs and Polysorbate/Product Degradation
Roundtable 3 Notes: Mass Spec 2021
-
Multi-Attribute Method (MAM) in Development vs. MAM in QC
Roundtable 2 Notes: Mass Spec 2021
-
Qualification and Validation of MS Methods 2021
Roundtable 1 Notes: Mass Spec 2021
-
Why and How to Move New Analytical Technologies from R&D to GMP
Roundtable 9 Notes: AT Europe 2020
-
Big Data - How Are Analytical Teams Addressing This, and Automation in Biopharmaceutical Development- an Answer or the Answer?
Roundtable 8 Notes: AT Europe 2020